Week In Review: 2 China Biopharmas Raise $1.4 Billion In Hong Kong IPOs

In May, the company completed a $354 million Shanghai IPO at a price that has now quadrupled after six months. From the start, WuXi planned to have a dual Shanghai-Hong Kong listing, following the …
( read original story …)

Related Post